Search alternatives:
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
ms decrease » _ decrease (Expand Search), a decrease (Expand Search), use decreased (Expand Search)
50 ms » 50 mg (Expand Search), 50 mm (Expand Search)
-
12381
-
12382
-
12383
-
12384
Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx
Published 2023“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”
-
12385
Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx
Published 2023“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”
-
12386
Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx
Published 2023“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”
-
12387
-
12388
-
12389
-
12390
-
12391
Computational design of substrate selective inhibition
Published 2020“…One is a competitive inhibitor of Ang-III (increases its K<sub>m</sub>), but non-competitive towards TRH (decreases its V<sub>max</sub>).</p></div>…”
-
12392
-
12393
-
12394
-
12395
-
12396
-
12397
-
12398
Growth factor concentration in 48 hours conditioned media (CM).
Published 2023“…Data are expressed as mean ± SEM. <u>In HCE-T cell culture supernatant</u>, 0.17 J/cm<sup>2</sup> rose bengal photodynamic therapy (RB-PDT) significantly increased HGF and FGFb concentration (p≤0.02) and significantly decreased TGF-β concentration (p<0.01), compared to controls (Ctrl). …”
-
12399
Image_1_Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19.TIF
Published 2020“…Five and 13 patients were hospital-acquired and community-acquired infection of SARS-CoV-2, respectively. …”
-
12400
Data_Sheet_1_Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19.docx
Published 2020“…Five and 13 patients were hospital-acquired and community-acquired infection of SARS-CoV-2, respectively. …”